Increased bleeding events with the addition of apixaban to the dual anti-platelet regimen for the treatment of patients with acute coronary syndrome: A meta-analysis

BACKGROUND: Dual anti-platelet therapy (DAPT) with aspirin and clopidogrel has been the mainstay of treatment for patients with acute coronary syndrome (ACS). However, the recurrence of thrombotic events, potential aspirin and clopidogrel hypo-responsiveness, and other limitations of DAPT have led t...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Jing, Zhuo, Xiaojun, Xiao, Mou, Jiang, Zhiming, Chen, Linlin, Devi Shamloll, Yashvina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
3400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282097/
https://www.ncbi.nlm.nih.gov/pubmed/33761699
http://dx.doi.org/10.1097/MD.0000000000025185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282097/
https://www.ncbi.nlm.nih.gov/pubmed/33761699
http://dx.doi.org/10.1097/MD.0000000000025185

Ejemplares similares